Berkshire Asset Management’s Celgene Corp CELG Stock Holding History

Berkshire Asset Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,886	Closed	-$333K	–	172
2015 Q1	$333K	Hold	2,886	–	–	0.06%	127
2014 Q4	$323K	Hold	2,886	–	–	0.06%	132
2014 Q3	$274K	Hold	2,886	–	–	0.05%	142
2014 Q2	$248K	Hold	2,886	–	–	0.05%	148
2014 Q1	$201K	Sell	2,886 -570	-16%	-$45.1K	0.04%	153
2013 Q4	$292K	Buy	3,456 +570	+20%	+$45.1K	0.06%	140
2013 Q3	$222K	Buy	+2,886	New	+$202K	0.05%	128

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Asset Management's CELG Position: Q2 2015 in Review

Berkshire Asset Management sold out of Celgene Corp (CELG) in Q2 2015, closing a stake of 2,886 shares — an estimated $333K sold.

Berkshire Asset Management first reported a position in CELG in Q3 2013 and held it in 7 quarters. The position peaked at $333K in Q1 2015. 1,201 funds tracked by Wall St. Rank hold CELG as of Q2 2015.

Berkshire Asset Management reported no remaining Celgene Corp position as of Q2 2015 after selling out during the quarter.
Berkshire Asset Management sold 2,886 Celgene Corp shares in Q2 2015, an estimated $333K.
Berkshire Asset Management first reported a position in Celgene Corp in Q3 2013 and held it in 7 quarters.
Berkshire Asset Management's Celgene Corp position peaked at $333K in Q1 2015.
1,201 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2015.

Based on Berkshire Asset Management's 13F filing for Q2 2015, filed 10 Jul 2015.